secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2026-03-23T23:59:59+00:00
Accession:  0001193125-26-119951
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptose amends CEO Rice's employment agreement; confirms no deferred compensation owed
--------------------------------------------------------------------------------

- First Amendment to CEO William Rice's employment agreement confirms no deferred compensation plan was ever established.
- Rice acknowledges sole responsibility for all individual taxes, penalties, and interest on benefits paid under agreement.
- Amendment clarifies that references to 'Deferred Compensation Plan' in prior agreements are disregarded.
- No change in Rice's role; continues as Chairman, President, and CEO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000119312526119951/0001193125-26-119951-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000119312526119951/d113888d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-119951

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer